{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:35:58Z","timestamp":1776695758580,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ctro.2023.100634","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T15:44:56Z","timestamp":1683128696000},"page":"100634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients\u2019 registration database, Proton-Net"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7508-7217","authenticated-orcid":false,"given":"Hideya","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-0337","authenticated-orcid":false,"given":"Masao","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1841-1399","authenticated-orcid":false,"given":"Tomoaki","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6632-4356","authenticated-orcid":false,"given":"Takashi","family":"Iizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2975-1452","authenticated-orcid":false,"given":"Osamu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3959-2114","authenticated-orcid":false,"given":"Norio","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8512-1316","authenticated-orcid":false,"given":"Takeshi","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-5420","authenticated-orcid":false,"given":"Masayuki","family":"Araya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-1688","authenticated-orcid":false,"given":"Takahiro","family":"Waki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1592-4524","authenticated-orcid":false,"given":"Takumi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5091-1078","authenticated-orcid":false,"given":"Masayuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2023.100634_b0005","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/cncr.33476","article-title":"The global, regional, and national burden of the gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"127","author":"Ouyang","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2023.100634_b0010","doi-asserted-by":"crossref","unstructured":"Borger DR, Tanabe KK, Fan KC, et al. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist. 2012;17:72-9.","DOI":"10.1634\/theoncologist.2011-0386"},{"issue":"02","key":"10.1016\/j.ctro.2023.100634_b0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2004-828895","article-title":"Surgical management of cholangiocarcinoma","volume":"24","author":"Jarnagin","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"9","key":"10.1016\/j.ctro.2023.100634_b0020","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cncr.29692","article-title":"Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma","volume":"122","author":"Esnaola","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2023.100634_b0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.semradonc.2018.06.003","article-title":"Radiotherapy for Biliary Tract Cancers","volume":"28","author":"Keane","year":"2018","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100634_b0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"Kopek","year":"2010","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2023.100634_b0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.adro.2016.10.008","article-title":"Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma","volume":"1","author":"Sandler","year":"2016","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100634_b0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.adro.2019.08.003","article-title":"Stereotactic body radiation therapy for cholangiocarcinoma: optimizing locoregional control with elective nodal irradiation","volume":"5","author":"Kozak","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"16","key":"10.1016\/j.ctro.2023.100634_b0045","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.3390\/cancers13163991","article-title":"Stereotactic body radiation therapy after chemotherapy for unresectable perihilar cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study","volume":"13","author":"Baak","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ctro.2023.100634_b0050","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/jgh.12843","article-title":"Proton beam therapy for unresectable intrahepatic cholangiocarcinoma","volume":"30","author":"Ohkawa","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ctro.2023.100634_b0055","first-page":"114","article-title":"Particle beam therapy for biliary duct carcinoma (proton and heavy iron beam radiotherapy)","volume":"32","author":"Terashima","year":"2018","journal-title":"Journal of Japan Biliary Association"},{"issue":"3","key":"10.1016\/j.ctro.2023.100634_b0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/COC.0000000000000646","article-title":"Clinical outcomes of patients with unresectable cholangiocarcinoma treated with proton beam therapy","volume":"43","author":"Hung","year":"2020","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100634_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-9-26","article-title":"Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma","volume":"9","author":"Makita","year":"2014","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100634_b0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ctro.2023.100634_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1096-9098(200010)75:2<89::AID-JSO3>3.0.CO;2-V","article-title":"Length and quality of survival following external beam radiotherapy combined with an expandable metallic stent for unresectable hilar cholangiocarcinoma","volume":"75","author":"Shinchi","year":"2000","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2023.100634_b0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2008.09.017","article-title":"Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas","volume":"74","author":"Shinohara","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2023.100634_b0085","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0360-3016(97)00299-X","article-title":"External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma","volume":"39","author":"Foo","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2023.100634_b0090","first-page":"102","article-title":"External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinoma","volume":"62","author":"Chen","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ctro.2023.100634_b0095","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.ejca.2014.08.013","article-title":"Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive 9902 phase II randomized study","volume":"50","author":"Phelip","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2023.100634_b0100","first-page":"737","article-title":"Radiochemotherapy with gemcitabine in unresectable extrahepatic cholangiocarcinoma: long-term results of a phase II study","volume":"36","author":"Autorino","year":"2016","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.ctro.2023.100634_b0105","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.21037\/jgo-20-245","article-title":"Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer","volume":"11","author":"Jethwa","year":"2020","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100634_b0110","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.radonc.2014.01.003","article-title":"Factors influencing survival outcome for radiotherapy for biliary tract cancer: a multicenter retrospective study","volume":"110","author":"Yoshioka","year":"2014","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100634_b0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/cam4.975","article-title":"Does radiotherapy still have a role in unresected biliary tract cancer?","volume":"6","author":"Pollom","year":"2017","journal-title":"Cancer Med"},{"issue":"13","key":"10.1016\/j.ctro.2023.100634_b0120","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1245\/s10434-017-6131-9","article-title":"Chemoradiation therapy for unresected extrahepatic cholangiocarcinoma: a propensity score-matched analysis","volume":"24","author":"Torgeson","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100634_b0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.seminoncol.2020.02.001","article-title":"Locally advanced rectal cancer: the past, present, and future","volume":"47","author":"Oronsky","year":"2020","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ctro.2023.100634_b0130","doi-asserted-by":"crossref","unstructured":"Avila S, Smani DA, Koay EJ. Radiation dose escalation for locally advanced unresectable intrahepatic and extrahepatic cholangiocarcinoma. Chin Clin Oncol. 2020;9:10.","DOI":"10.21037\/cco.2019.12.05"},{"issue":"3","key":"10.1016\/j.ctro.2023.100634_b0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","article-title":"Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis","volume":"34","author":"Tao","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2023.100634_b0140","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0360-3016(94)90115-5","article-title":"The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer","volume":"28","author":"Alden","year":"1994","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"issue":"4","key":"10.1016\/j.ctro.2023.100634_b0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0360-3016(02)02845-6","article-title":"Limitations of conventional doses of chemoradiation for unresectable biliary cancer","volume":"53","author":"Crane","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2023.100634_b0150","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.ctro.2023.100634_b0155","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ctro.2023.100634_b0160","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1002\/cam4.1734","article-title":"Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma","volume":"7","author":"Elganainy","year":"2018","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ctro.2023.100634_b0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.21037\/jgo.2017.01.20","article-title":"High dose chemoradiation for unresectable hilar cholangiocarcinomas using intensity modulated external beam radiotherapy: a single tertiary care centre experience","volume":"8","author":"Engineer","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ctro.2023.100634_b0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00066-018-1367-2","article-title":"Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review","volume":"195","author":"Lee","year":"2019","journal-title":"Strahlenther Onkol"},{"issue":"1097","key":"10.1016\/j.ctro.2023.100634_b0175","doi-asserted-by":"crossref","first-page":"20180688","DOI":"10.1259\/bjr.20180688","article-title":"Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review","volume":"92","author":"Frakulli","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2023.100634_b0180","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.18632\/oncotarget.27028","article-title":"Japan Carbon-Ion Radiation Oncology Study Group. Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by the Japan carbon-ion radiation oncology study group (J-CROS)","volume":"10","author":"Kasuya","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctro.2023.100634_b0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2018.11.015","article-title":"Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma","volume":"132","author":"Brunner","year":"2019","journal-title":"Radiother Oncol"},{"issue":"2-3","key":"10.1016\/j.ctro.2023.100634_b0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000524582","article-title":"Space-making particle therapy for unresectable hilar cholangiocarcinoma","volume":"39","author":"Hashimoto","year":"2022","journal-title":"Dig Surg"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:10:51Z","timestamp":1762503051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"alternative-id":["S2405630823000599"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100634","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients\u2019 registration database, Proton-Net","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100634"}}